PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-12.98%
Revenue decline while Healthcare median is -1.16%. Seth Klarman would investigate if market share loss is temporary.
-15.76%
Cost reduction while Healthcare median is -2.41%. Seth Klarman would investigate competitive advantage potential.
-5.67%
Gross profit decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
8.39%
Margin change of 8.39% versus flat Healthcare margins. Walter Schloss would verify quality.
-73.35%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-7.64%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
-9.84%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
154.29%
Other expenses change of 154.29% versus flat Healthcare costs. Walter Schloss would verify efficiency.
14.76%
Operating expenses change of 14.76% versus flat Healthcare costs. Walter Schloss would verify control.
-5.54%
Total costs reduction while Healthcare median is -7.97%. Seth Klarman would investigate advantages.
-55.84%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
0.26%
D&A growth while Healthcare reduces D&A. Peter Lynch would examine asset strategy.
-28.36%
EBITDA decline while Healthcare median is -3.75%. Seth Klarman would investigate causes.
-18.55%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-77.54%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-104.02%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
113.69%
Other expenses growth while Healthcare reduces costs. Peter Lynch would examine differences.
21.48%
Pre-tax income growth while Healthcare declines. Peter Lynch would examine advantages.
9.77%
Margin change of 9.77% versus flat Healthcare. Walter Schloss would verify quality.
103.21%
Tax expense change of 103.21% versus flat Healthcare. Walter Schloss would verify strategy.
-23.37%
Net income decline while Healthcare median is -1.51%. Seth Klarman would investigate causes.
-41.77%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-11.75%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-11.75%
Diluted EPS decline while Healthcare median is 0.64%. Seth Klarman would investigate causes.
10.30%
Share count reduction below 50% of Healthcare median of 0.49%. Jim Chanos would check for issues.
10.30%
Diluted share reduction below 50% of Healthcare median of 0.46%. Jim Chanos would check for issues.